Clinical Trial Update: The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of pioglitazone and rosiglitazone on atherosclerotic and inflammatory markers in patients with metabolic syndrome. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED